Effect of switching branded risedronate to branded or generic alendronate on medication compliance with weekly bisphosphonates: a cohort study utilizing the dapi prescription claims database

Schüssel K Czeche S Möhrke W Schulz M

7. Jahrestagung der Deutschen Gesellschaft für Epidemiologie (DGEpi), 26. - 29. September 2012, Regensburg.

Abstract Schuessel DGEpi 2012 Regensburg

Conflicts of interests: Eine ähnliche, Vorläufer-Studie wurde finanziell unterstützt durch Procter & Gamble Pharmaceuticals-Germany GmbH, jetzt Warner Chilcott Deutschland GmbH. WM war Angestellter bei Procter & Gamble Pharmaceuticals-Germany GmbH / Warner Chilcott Deutschland GmbH. A similar, preceding study was financially supported by Procter & Gamble Pharmaceuticals-Germany GmbH, now Warner Chilcott Deutschland GmbH. WM was employee of Procter & Gamble Pharmaceuticals-Germany GmbH / Warner Chilcott Deutschland GmbH.

Impact of rebate contract legislation on generic substitution of valproate – a retrospective study of ambulatory drug dispensing in the DAPI database

Incidence of thyroid hormone therapy in patients treated with sorafenib or sunitinib

Effect of generic switch on pharmacy refill compliance after ramipril patent expiry – a retrospective study using the DAPI database

Treatment duration (persistence) of basal insulin supported oral therapy (BOT) in Type-2 diabetic patients: comparison of insulin glargine with NPH insulin.

Comparison of different ways of calculation (DDD vs. SPC) to determine persistence and compliance with beta blockers in the DAPI database.

Generic switch after ramipril patent expiry is not associated with decreased pharmacy refill compliance: a retrospective study using the DAPI database.

Association between generic substitution of valproate and therapeutic modification of antiepileptic therapy – a cohort study with time-dependent exposure utilizing the DAPI ambulatory drug claims data